Dechra Pharmaceuticals

DPH

GB0009633180

Delayed London S.E. Other stock markets 01:00:00 16/01/2024 pm IST			5-day change	1st Jan Change
3,866 ^GBX	-.--%		-.--%	+0.21%

15/04	Dechra Pharmaceuticals Limited acquired 33.34% stake in STEM Animal Health Inc.	CI
11/04	Dechra Pharmaceuticals Limited reached agreement in principle to acquire 33.34% stake in STEM Animal Health Inc. for $4.7 million.	CI

Dechra Pharmaceuticals plc Provides Earnings Guidance for the Year 2021

February 22, 2021 at 12:30 pm IST

Dechra Pharmaceuticals PLC provided earnings guidance for the year 2021. For the year, overall the outlook for the full year remains positive and in line with January trading update.

Latest news about Dechra Pharmaceuticals

Dechra Pharmaceuticals Limited acquired 33.34% stake in STEM Animal Health Inc.	15/04	CI
Dechra Pharmaceuticals Limited reached agreement in principle to acquire 33.34% stake in STEM Animal Health Inc. for $4.7 million.	11/04	CI
Dechra Group Holdings Limited Appoints Paul Nicholas Sandland as Director	09/04	CI
Dechra Group Holdings Limited Appoints Ian David Page as Director	09/04	CI
Dechra Group Holdings Limited Announces Resignation of Thomas Spicer as Director	09/04	CI
Dechra Group Holdings Limited Announces Resignation of Anthony Santospirito as Director	09/04	CI
Dechra Group Holdings Limited Announces Resignation of Sara Huda as Director	09/04	CI
Stocks slump as Fed rate cut hope dwindles	17/01	AN
Dechra Pharmaceuticals Delists From London Bourse Following Freya Bidco’s Takeover	17/01	MT
EQT's Freya Bidco Completes Dechra Pharmaceuticals Purchase	16/01	MT
Dechra Pharmaceuticals PLC(LSE:DPH) dropped from FTSE 100 Index	16/01	CI
Dechra Pharmaceuticals PLC(LSE:DPH) dropped from FTSE All-World Index	16/01	CI
Dechra Pharmaceuticals PLC(LSE:DPH) dropped from FTSE 350 Index	16/01	CI
Dechra Pharmaceuticals PLC(LSE:DPH) dropped from FTSE All-Share Index	16/01	CI
Dechra Pharmaceuticals PLC(LSE:DPH) dropped from FTSE 350 (Ex Investment Companies) Index	16/01	CI
Dechra Pharmaceuticals PLC(LSE:DPH) dropped from S&P Global BMI Index	16/01	CI
EQT X EUR SCSp and EQT X USD SCSp managed by Eqt Fund Management S.à R.L. and Luxinva SA (the Offerors) completed the acquisition of Dechra Pharmaceuticals PLC.	16/01	CI
Persimmon to replace outbound FTSE 100 constituent Dechra	12/01	AN
EMEA Morning Briefing : Markets to Track Fresh Middle East Tensions	12/01	DJ
EU clears Dechra Pharmaceuticals takeover by EQT funds	27/12	AN
EQT's Dechra Takeover to Become Effective in Mid-January 2024	27/12	MT
EQT's Takeover of Dechra Pharmaceuticals Gets EU Antitrust Regulator's Nod	22/12	MT
Inchcape to appoint Jerry Buhlmann to chair board of directors from May	14/12	AN
EQT Secures Australian Nod for Dechra Pharmaceuticals Takeover	30/11	MT
FTSE 100 Ends Down, Falling Behind European Peers	29/11	DJ

Dechra Pharmaceuticals PLC specializes in the manufacturing and marketing of veterinary pharmaceutical products. Net sales break down by family of products as follows: - companion animal products (74.6%); - food producing animal products (11.5%); - equine health products (7.3%); - animal feeds (5.1%); - other (1.5%): products manufactured by third parties. Net sales are distributed geographically as follows: the United Kingdom (8.5%), Germany (9.2%), Europe (31.2%), the United States (37.9%) and other (13.2%).

Sector

More about the company